Skip to search formSkip to main contentSkip to account menu

Urofollitropin 75 UNT Injection [Bravelle]

Known as: Bravelle 75 UNT Injection, Follicle Stimulating Hormone 75 INTERNATIONAL UNITS In 1 VIAL INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bravelle], Follicle Stimulating Hormone 75 INTERNATIONAL UNITS In 1 VIAL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Bravelle] 
National Institutes of Health

Related topics

Related topics

9 relations
BravelleFollicle Stimulating HormoneInjectionLactose Monohydrate

Broader (1)

Urofollitropin 75 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Initiation of ovarian stimulation independent of the menstrual cycle: a case–control study
PurposeIn the GnRH-antagonist protocol, ovarian stimulation with gonadotropins typically commences on cycle day 2 or 3… 
2007
2007
Endometrin® for Luteal Phase Support in a Randomized, Controlled, Open-Label, Prospective IVF Clinical Trial Using a Combination of Menopur® and Bravelle®
2003
2003
Bravelle™ (highly-purified hFSH) vs. Follistim® (rFSH) in IVF: pooled analysis from two prospective, randomized clinical trials
2002
2002
Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study.
OBJECTIVE To compare the efficacy and safety of Bravelle s.c., Bravelle i.m., and Follistim s.c. in patients undergoing… 
2002
2002
The bioactivities of FSH and LH are unaltered by mixing highly purified human-derived FSH (Bravelle™) and HMG (HP-Repronex®) together in the same diluent and in the same syringe
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)